Enveric Biosciences, Inc.
ENVB
$1.46
$0.042.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.73M | -8.22M | -8.77M | -9.73M | -9.94M |
| Total Depreciation and Amortization | 153.90K | 157.10K | 200.90K | 243.90K | 288.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 561.40K | 642.60K | 725.60K | 1.34M | 1.65M |
| Change in Net Operating Assets | -547.50K | -586.00K | -296.00K | 481.20K | 1.48M |
| Cash from Operations | -8.56M | -8.01M | -8.14M | -7.67M | -6.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.05M | 8.63M | 10.58M | 8.37M | 5.90M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.80K | -- | -- | -20.40K | -20.50K |
| Cash from Financing | 14.03M | 8.63M | 10.58M | 8.35M | 5.88M |
| Foreign Exchange rate Adjustments | -22.00K | -12.70K | -1.50K | -39.70K | -11.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.45M | 614.40K | 2.44M | 645.90K | -652.80K |